Eddie Patel Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Eddie Patel Inc’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,020	Closed	-$203K	–	98
2025 Q4	$203K	Buy	+7,020	New	+$211K	0.15%	104

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Eddie Patel Inc's ARKG Position: Q1 2026 in Review

Eddie Patel Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 7,020 shares — an estimated $203K sold.

Eddie Patel Inc first reported a position in ARKG in Q4 2025 and held it in 1 quarter. The position peaked at $203K in Q4 2025. 220 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Eddie Patel Inc reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
Eddie Patel Inc sold 7,020 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $203K.
Eddie Patel Inc first reported a position in ARK Genomic Revolution ETF in Q4 2025 and held it in 1 quarter.
Eddie Patel Inc's ARK Genomic Revolution ETF position peaked at $203K in Q4 2025.
220 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Eddie Patel Inc's 13F filing for Q1 2026, filed 11 May 2026.